Research graph
References from Antithrombotic Management after Successful Catheter Ablation for Atrial Fibrillation: Meta-analysis of the ALONE-AF and OCEAN Trials. Local targets link to admitted publications; unresolved targets remain external evidence.
Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
10.1161/cir.0000000000001193 · 2024 · External reference
ESC Scientific Document Group. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
10.1093/eurheartj/ehae176 · 2024 · External reference
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation
10.1007/s10840-024-01771-5 · 2024 · External reference
ALONE-AF Investigators. Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial
10.1001/jama.2025.14679 · 2025 · External reference
OCEAN Investigators. Antithrombotic therapy after successful catheter ablation for atrial fibrillation
10.1056/nejmoa2509688 · 2026 · External reference
Retrieving randomized controlled trials from medline: a comparison of 38 published search filters
10.1111/j.1471-1842.2008.00827.x · 2009 · External reference
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
10.1016/j.jclinepi.2010.04.026 · 2011 · External reference
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials
10.1161/circulationaha.123.067512 · 2024 · External reference
Catheter ablation of atrial fibrillation in heart failure with impaired systolic function: an updated meta-analysis of randomized controlled trials
10.1097/jcma.0000000000000823 · 2023 · External reference
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
10.1136/bmj.d124 · 2011 · External reference
Ablation to reduce atrial fibrillation burden and improve outcomes. JACC Review Topic of the Week
10.1016/j.jacc.2023.06.029 · 2023 · External reference
Anticoagulation with edoxaban in patients with atrial high-rate episodes
10.1056/nejmc2312837 · 2023 · External reference
ARTESIA Investigators. Apixaban for stroke prevention in subclinical atrial fibrillation
10.1056/nejmoa2310234 · 2024 · External reference
Bleeding risks with novel oral anticoagulants versus aspirin: a meta-analysis
10.1186/s12959-021-00322-6 · 2021 · External reference
Major bleeding with apixaban vs aspirin: a subanalysis of the ARTESiA randomized clinical trial
10.1001/jamacardio.2025.4151 · 2025 · External reference
Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design
10.1161/circulationaha.121.056109 · 2022 · External reference
Discerning the incidence of symptomatic and asymptomatic atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study
10.1001/jamainternmed.2013.1561 · 2013 · External reference
Expert opinion on continuous rhythm monitoring of patients with atrial fibrillation for candidates or patients who have already undergone ablation
10.1016/j.ijcard.2020.02.001 · 2020 · External reference
